PE20070494A1 - COMPUESTOS DERIVADOS DE PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA COMO INHIBIDORES DE LA ENZIMA INTEGRASA DE VIH - Google Patents

COMPUESTOS DERIVADOS DE PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA COMO INHIBIDORES DE LA ENZIMA INTEGRASA DE VIH

Info

Publication number
PE20070494A1
PE20070494A1 PE2006001216A PE2006001216A PE20070494A1 PE 20070494 A1 PE20070494 A1 PE 20070494A1 PE 2006001216 A PE2006001216 A PE 2006001216A PE 2006001216 A PE2006001216 A PE 2006001216A PE 20070494 A1 PE20070494 A1 PE 20070494A1
Authority
PE
Peru
Prior art keywords
ona
pirrolo
naphthyridin
alkyl
inhibitors
Prior art date
Application number
PE2006001216A
Other languages
English (en)
Inventor
Klaus Ruprecht Dress
Ted William Johnson
Steven Paul Tanis
Huicun Zhu
Michael Bruno Plewe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070494(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20070494A1 publication Critical patent/PE20070494A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A COMPUESTOS DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C8), ALQUENILO(C2-C8) O HETEROALQUILO(C1-C8) OPCIONALMENTE SUSTITUIDOS CON HALO, CN, ALQUILO(C1-C8), ENTRE OTROS; R2 ES H O ALQUILO(C1-C8); R3 ES ALQUILO(C1-C8), HETEROALQUILO(C1-C8), ARILO(C6-C14), ENTRE OTROS; Z ES -(CR4R4)n- DONDE R4 ES H, HALO, ALQUILO(C1-C8), CICLOALQUILO(C3-C8), ENTRE OTROS; R5 ES H, HETEROALQUILO(C1-C8), ARILO(C6-14), ALQUENILO(C2-C8), ENTRE OTROS; R6 ES H. SON COMPUESTOS PREFERIDOS: 8-BUTIL-3-(4-FLUOROBENCIL)-7-HIDROXI-3,7,8,9-TETRAHIDRO-6H-PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA, 3-(4-FLUOROBENCIL)-7-HIDROXI-1-({[(2S)-2-HIDROXIPROPIL]AMINO}METIL)-3,7-DIHIDRO-6H-PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA, 1-{[ETIL(METIL)AMINO]METIL}-3-(4-FLUOROBENCIL)-7-HIDROXI-3,7-DIHIDRO-6H-PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ENZIMA INTEGRASA DEL VIRUS DE INMUNODEFICIENCIA HUMANA (VIH) SIENDO UTILES EN EL TRATAMIENTO DE SIDA
PE2006001216A 2005-10-07 2006-10-05 COMPUESTOS DERIVADOS DE PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA COMO INHIBIDORES DE LA ENZIMA INTEGRASA DE VIH PE20070494A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20

Publications (1)

Publication Number Publication Date
PE20070494A1 true PE20070494A1 (es) 2007-06-13

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001216A PE20070494A1 (es) 2005-10-07 2006-10-05 COMPUESTOS DERIVADOS DE PIRROLO[2,3-c]-1,7-NAFTIRIDIN-6-ONA COMO INHIBIDORES DE LA ENZIMA INTEGRASA DE VIH

Country Status (21)

Country Link
US (1) US20070099915A1 (es)
EP (1) EP1934220A1 (es)
JP (1) JP2009511463A (es)
KR (1) KR20080042171A (es)
AP (1) AP2008004400A0 (es)
AR (1) AR061398A1 (es)
AU (1) AU2006300926A1 (es)
BR (1) BRPI0616657A2 (es)
CA (1) CA2623506A1 (es)
CR (1) CR9859A (es)
EA (1) EA200800758A1 (es)
IL (1) IL189939A0 (es)
MA (1) MA29855B1 (es)
NL (1) NL2000255A1 (es)
NO (1) NO20081230L (es)
PE (1) PE20070494A1 (es)
RS (1) RS20080141A (es)
SV (1) SV2009002864A (es)
TW (1) TW200800219A (es)
UY (1) UY29843A1 (es)
WO (1) WO2007042883A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
US5616609A (en) * 1991-08-08 1997-04-01 Ikekawa; Tetsuro Carcinostatic compound and production thereof
WO1995003311A1 (fr) * 1993-07-19 1995-02-02 Xuande Luo Derives de qinghaosu utilises pour lutter contre le sida
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
AU8009900A (en) * 1999-10-13 2001-04-23 Merck & Co., Inc. Hiv integrase inhibitors
WO2001098248A2 (en) * 2000-06-16 2001-12-27 Bristol-Myers Squibb Company Hiv integrase inhibitors
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) * 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
WO2005103051A1 (en) * 2004-04-26 2005-11-03 Pfizer Inc. Inhibitors of the hiv integrase enzyme
WO2006027694A1 (en) * 2004-09-07 2006-03-16 Pfizer Inc. Inhibitors of the hiv integrase enzyme

Also Published As

Publication number Publication date
US20070099915A1 (en) 2007-05-03
TW200800219A (en) 2008-01-01
IL189939A0 (en) 2008-08-07
EA200800758A1 (ru) 2008-08-29
EP1934220A1 (en) 2008-06-25
MA29855B1 (fr) 2008-10-03
BRPI0616657A2 (pt) 2011-06-28
CR9859A (es) 2008-06-20
RS20080141A (en) 2009-07-15
JP2009511463A (ja) 2009-03-19
NL2000255A1 (nl) 2007-04-11
NO20081230L (no) 2008-04-08
AU2006300926A1 (en) 2007-04-19
WO2007042883A1 (en) 2007-04-19
AP2008004400A0 (en) 2008-04-30
AR061398A1 (es) 2008-08-27
SV2009002864A (es) 2009-02-19
CA2623506A1 (en) 2007-04-19
KR20080042171A (ko) 2008-05-14
UY29843A1 (es) 2007-05-31

Similar Documents

Publication Publication Date Title
PE20061148A1 (es) Sal potasica de n-(4-fluorobencil)-5-hidroxi-1-metil-2-(1-metil-1-{[(5-metil-1,3,4-oxadiazol-2-il)carbonil]amino}etil)-6-oxo-1,6-dihidropirimidin-4-carboxamida
PE20070531A1 (es) Compuestos heterociclicos como inhibidores de aspartil proteasas
EA200802203A1 (ru) Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов
PE20070115A1 (es) Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20071136A1 (es) Derivados de anilina sustituida como antagonistas de la histamina h3
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
BRPI0514738A (pt) derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos
UY29703A1 (es) "inhibidores macrocíclicos del virus de la hepatitis c"
PE20120632A1 (es) Inhibidores de bace
AR055774A1 (es) Fenilacetamidas apropiadas como inhibidores de proteina quinasa
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
ATE534626T1 (de) Piperazinamidine als antivirale mittel
PE20121479A1 (es) Inhibidores del virus de la hepatitis c
MX2009010503A (es) Compuestos heterociclicos antiviricos.
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
GEP20125456B (en) Azetidines as mek inhibitors for the treatment of proliferative diseases
ATE545407T1 (de) Pharmazeutische formulierung von apomorphin für die bukkale verabreichung
PE20071177A1 (es) Derivados de 3,5-piridina como inhibidores de renina
PE20070352A1 (es) Compuestos de imidazol sustituidos como inhibidores de ksp
BRPI0511874A (pt) derivados da pirrolopiridina

Legal Events

Date Code Title Description
FD Application declared void or lapsed